RxDoctor Payments Data

Adeel Kaiser, MD

Radiation Oncology · Miami, FLNPI 1881883536

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (59.8%), food and beverage and education — rather than concentrated in one kind of arrangement. 8 manufacturers reported payments, led by Accuray Incorporated at 59.8% of the total. 2025 is the largest year on record at $1,203, 8.7 times the $139 reported in 2019.

$1,672in general payments, 2019–2025

Across 12 payments — averaging $139.30 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Accuray Incorporated$1K
  • Pfizer$277
  • Boston Scientific$127
  • Varian Medical Systems, Inc.$90
  • Blue Earth Diagnostics$55
  • Eisai Inc.$49
  • plus $74 from 2 others
$407,156in research payments, 2019–2025

Across 10 payments — averaging $40,716 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Novartis$407K

What the payments were for

  • Speaking & faculty fees$1,00060%
  • Food & beverage$62337%
  • Education$493%

General payments by program year

19
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,672 in reported general payments places this provider in the 65th percentile of 465 radiation oncology providers in Florida.

See all radiation oncology providers in Florida

Medicare billing

Part B allowed, 2024
$116,140
Medicare patients
274
Services billed
1,316

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Miami

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →